Effect of Probiotic Fermented Dairy Drinks on Intestinal Immune Response

This study has been completed.
Istituto Clinico Humanitas
Information provided by:
Danone Research
ClinicalTrials.gov Identifier:
First received: September 28, 2009
Last updated: June 15, 2011
Last verified: June 2011
The purpose of this study is to investigate whether two different fermented dairy drinks consumed daily could have an effect on the intestinal immune response in healthy subjects.

Condition Intervention
Dietary Supplement: 1- Dairy drink containing probiotics A
Dietary Supplement: 2- Dairy drink containing probiotics B
Dietary Supplement: 3- Dairy drink without probiotics (control)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Pilot Study on the Effects of Probiotic Fermented Dairy Drinks on the Intestinal Immune Response in Healthy Adults

Further study details as provided by Danone Research:

Estimated Enrollment: 33
Study Start Date: September 2009
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1-Test product A
1-Dairy product containing probiotics A (test product A)
Dietary Supplement: 1- Dairy drink containing probiotics A
1- Dairy drink containing probiotics A
Active Comparator: 2-Test product B
2-Dairy product containing probiotics B (test product B)
Dietary Supplement: 2- Dairy drink containing probiotics B
2- Dairy drink containing probiotics B
Sham Comparator: 3-Control
3-Dairy product without probiotics (control)
Dietary Supplement: 3- Dairy drink without probiotics (control)
3- Dairy drink without probiotics (control)


Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy male/female subjects aged from 18 to 45 years (bounds included).
  • Subjects with none of the symptoms of gastrointestinal infectious diseases
  • Subjects with a body mass index (BMI) between 19 and 30 kg/m² (bounds included).
  • Subjects who accept to be submitted to an alimentary restriction of product with OTC and foods containing probiotics and/or prebiotics
  • Subjects who regularly consume and appreciate dairy products
  • Subjects who have not consumed any products or OTCs containing probiotics within the last three months.

Exclusion Criteria:

  • Subjects in a situation that, in the investigator opinion, could interfere with optimal participation in the present study (e.g. non dairy-products consumer) or could constitute a special risk for the subject.
  • Subjects with allergies or hypersensitivity to any component of the study product (e.g: allergy or hypersensitivity to milk proteins, or lactose intolerance)
  • Subjects with any food allergy
  • Subjects with auto-immune or with chronic disease or with a history of chronic metabolic or gastrointestinal.
  • Subjects who have had any surgery or intervention requiring general anaesthesia in the last 4 weeks..
  • Subjects with special diet requirements
  • For female subjects: pregnancy, breast feeding or no method of contraceptive used
  • Subjects participating in any other interventional study concomitantly or within 4 weeks of the study entry date.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Silvio Danese, MD, PhD, Istituto Clinico Humanitas
ClinicalTrials.gov Identifier: NCT00987311     History of Changes
Other Study ID Numbers: NU311 
Study First Received: September 28, 2009
Last Updated: June 15, 2011
Health Authority: Italy: Ethics Committee

Keywords provided by Danone Research:
intestinal immune system
healthy subjects
dairy drink
Healthy adults

ClinicalTrials.gov processed this record on April 27, 2016